Daily Aspirin Regimen Raises Hemorrhage Risk in Elderly
|
By HospiMedica International staff writers Posted on 24 Sep 2018 |
|
The use of low-dose aspirin as a primary prevention strategy in older adults results in a significantly higher risk of major hemorrhage, according to a new study.
Researchers at Monash University (Melbourne, Australia), Hennepin Healthcare (Minneapolis, MN, USA), and other institutions conducted a study that enrolled 19,114 community-dwelling men and women in Australia and the United States who were 70 years of age or older, and did not have cardiovascular disease (CVD), dementia, or disability. Participants were randomly assigned to receive 100 mg of enteric-coated aspirin (9,525 people) or placebo (9,589). The primary end point was a composite of death, dementia, or persistent physical disability. Secondary end points included major hemorrhage and CVD.
The results revealed that after a median of 4.7 years of follow-up, the rate of CVD--defined as fatal coronary heart disease, nonfatal myocardial infarction (MI), fatal or nonfatal stroke, or hospitalization for heart failure--was 10.7 events per 1,000 person-years in the aspirin group, and 11.3 events per 1,000 person-years in the placebo group. The rate of major hemorrhage was 8.6 events per 1,000 person-years and 6.2 events per 1,000 person-years, respectively, or 38% higher. The study was published on September 16, 2018, in the New England Journal of Medicine (NEJM).
“The take-home message of such a complex, large, placebo-controlled study is that healthy older people contemplating how best to preserve their health will be unlikely to benefit from aspirin,” said lead author Professor John McNeil, PhD, director of the Monash University department of epidemiology and preventive medicine. “It means millions of healthy older people around the world who are taking low-dose aspirin without a medical reason may be doing so unnecessarily, because the study showed no overall benefit to offset the risk of bleeding.”
Low-dose aspirin is among the most widely used agents for the prevention of CVD. Its efficacy has been established in secondary prevention trials, in which the benefits associated with reducing the rates of both MI and ischemic stroke appear to outweigh the risk of hemorrhage. But the role of low-dose aspirin as a primary prevention strategy remains debated. In elderly populations, the risk of CVD is higher and the potential benefits of aspirin may accordingly be greater than in younger populations; however, an increased risk of bleeding has also been observed in the elderly age group.
Related Links:
Monash University
Hennepin Healthcare
Researchers at Monash University (Melbourne, Australia), Hennepin Healthcare (Minneapolis, MN, USA), and other institutions conducted a study that enrolled 19,114 community-dwelling men and women in Australia and the United States who were 70 years of age or older, and did not have cardiovascular disease (CVD), dementia, or disability. Participants were randomly assigned to receive 100 mg of enteric-coated aspirin (9,525 people) or placebo (9,589). The primary end point was a composite of death, dementia, or persistent physical disability. Secondary end points included major hemorrhage and CVD.
The results revealed that after a median of 4.7 years of follow-up, the rate of CVD--defined as fatal coronary heart disease, nonfatal myocardial infarction (MI), fatal or nonfatal stroke, or hospitalization for heart failure--was 10.7 events per 1,000 person-years in the aspirin group, and 11.3 events per 1,000 person-years in the placebo group. The rate of major hemorrhage was 8.6 events per 1,000 person-years and 6.2 events per 1,000 person-years, respectively, or 38% higher. The study was published on September 16, 2018, in the New England Journal of Medicine (NEJM).
“The take-home message of such a complex, large, placebo-controlled study is that healthy older people contemplating how best to preserve their health will be unlikely to benefit from aspirin,” said lead author Professor John McNeil, PhD, director of the Monash University department of epidemiology and preventive medicine. “It means millions of healthy older people around the world who are taking low-dose aspirin without a medical reason may be doing so unnecessarily, because the study showed no overall benefit to offset the risk of bleeding.”
Low-dose aspirin is among the most widely used agents for the prevention of CVD. Its efficacy has been established in secondary prevention trials, in which the benefits associated with reducing the rates of both MI and ischemic stroke appear to outweigh the risk of hemorrhage. But the role of low-dose aspirin as a primary prevention strategy remains debated. In elderly populations, the risk of CVD is higher and the potential benefits of aspirin may accordingly be greater than in younger populations; however, an increased risk of bleeding has also been observed in the elderly age group.
Related Links:
Monash University
Hennepin Healthcare
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Pediatric Mask
Respire SOFT
Patient Monitoring System
AlarmSense
Latest Critical Care News
- Invisible Skin Sensors Could Transform Everyday Biosignal Monitoring
- Patient-Specific Artery-on-a-Chip Refines Stroke Risk Stratification
- Existing Cardiovascular Risk Calculators Predict Several Common Cancers
- New Neurovascular Guidewire Enhances Access and Control in Stroke Thrombectomy
- AI Tool Automates EEG Analysis and Flags Clinically Relevant Abnormalities
- New Risk Models Improve Sudden Cardiac Arrest Prediction
- Low-Cost Antiseptic Regimen Reduces Bacteria Linked to Newborn Infections
- Collaborative ICU Admission Process Cuts Time to Critical Care Involvement by Half
- AI System Predicts Heart Failure Risk Years in Advance from Holter ECG
- Wearable Microneedle Patch Monitors Antibiotic Levels in Real Time
- AI Analysis of EMS Calls Aids Pediatric Trauma Decision-Making
- Noninvasive Silk Sensor Could Transform Care for Premature Infants
- AI Tool Supports Noninvasive Continuous Dyspnea Monitoring in Ventilated Patients
- AI Identifies Hidden Stroke Risk Through At-Home Behavior Patterns
- Home Exercise Program Advances Recovery After Aortic Dissection
- Multi-Night Home Monitoring Reduces Sleep Apnea Misdiagnosis
Channels
Artificial Intelligence
view channel
New AI Tool Identifies Support Needs in Spinal Cord Stimulation
Chronic pain patients implanted with spinal cord stimulation systems often need timely therapy adjustments and education between clinic visits. Detecting subtle changes in behavior or device use that precede... Read more
AI Tool Predicts Chronic Kidney Disease Risk in Diabetes
Chronic kidney disease is a common and serious complication of type 2 diabetes and often progresses without obvious early symptoms, increasing morbidity and straining health systems. Many risk models were... Read more
Surgical Techniques
view channel
Reusable Pulse Oximetry Sensor Improves Accuracy Across Skin Tones
Pulse oximetry is ubiquitous in critical and perioperative care, guiding interventions by indicating a patient’s oxygenation status. Yet signal quality can be affected by physiological, clinical, and technical... Read more
Implantable Neural Interface Undergoes First Real-World Surgical Validation
ABILITY Neurotech has initiated first-in-human evaluation of its fully implantable brain-computer interface (BCI) at the Department of Neurosurgery, Technical University of Munich (TUM) University Hospital... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
Smartwatch Monitoring Identifies Abnormal Vital Signs Before Routine Checks
Post-surgical inpatients often undergo frequent vital signs checks that interrupt rest and require substantial nursing time. Intermittent manual observations can also delay recognition of early physiological... Read more
Weekly Remote Symptom Monitoring Improves Symptom Control in Advanced Cancer
Patients receiving treatment for advanced cancer often struggle with uncontrolled symptoms and fragmented communication with clinicians. These gaps can impair daily function, increase emergency department... Read more
Point of Care
view channel
New Brain Ultrasound Platform Enables Bedside Postoperative Imaging
Transporting postoperative patients for CT or MRI can create operational burdens, delays, and disruptions in care. Bedside visualization may help reduce transport demands, lower radiation exposure, and... Read more
Handheld Ultrasound Expands Point-of-Care Imaging Access in Brazil
Rapid access to diagnostic imaging is essential across hospitals, emergency departments, clinics, and municipal health systems, but large markets still face uneven availability, particularly in rural regions.... Read more
Business
view channel
AI Care Platform Adds Quantitative MRI Analysis for Multiple Sclerosis
Neurodegenerative diseases such as multiple sclerosis require timely identification and coordinated, long-term management. As health systems seek consistent decision-making at scale, quantitative neuroimaging... Read more
